Citation 138964

OHSHIMA,H: YOSHIE,Y: AURIOL,S: GILIBERT,I:. (1998). ANTIOXIDANT AND PRO-OXIDANT ACTIONS OF FLAVONOIDS: EFFECTS ON DNA DAMAGE INDUCED BY NITRIC OXIDE, PEROXYNITRITE AND NITROXYL ANION.. 25(9)

Citation Details

Title	ANTIOXIDANT AND PRO-OXIDANT ACTIONS OF FLAVONOIDS: EFFECTS ON DNA DAMAGE INDUCED BY NITRIC OXIDE, PEROXYNITRITE AND NITROXYL ANION.
Authors	OHSHIMA,H: YOSHIE,Y: AURIOL,S: GILIBERT,I:
Year	1998
Volume	25
Issue	9

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
2	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	INACTIVE
3	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	APIGENIN	ACTIVE
4	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	WEAK ACTIVITY
5	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	ACTIVE
6	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	BAICALEIN	ACTIVE
7	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	INACTIVE
8	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	INACTIVE
9	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CAFFEIC ACID	ACTIVE
10	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	INACTIVE
11	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	WEAK ACTIVITY
12	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,(+):	ACTIVE
13	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHOL	WEAK ACTIVITY
14	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHOL	ACTIVE
15	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHOL	WEAK ACTIVITY
16	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CYANIDIN	WEAK ACTIVITY
17	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CYANIDIN	ACTIVE
18	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CYANIDIN	INACTIVE
19	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHINIDIN	WEAK ACTIVITY
20	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHINIDIN	ACTIVE
21	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHINIDIN	INACTIVE
22	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	INACTIVE
23	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	WEAK ACTIVITY
24	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN,EPI: (-):	ACTIVE
25	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN-3-O-GALLATE,EPI: (-):	INACTIVE
26	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
27	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	CATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
28	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN,EPI: (-):	INACTIVE
29	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN,EPI: (-):	ACTIVE
30	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN,EPI: (-):	ACTIVE
31	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	INACTIVE
32	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
33	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLOCATECHIN-3-O-GALLATE,EPI: (-):	ACTIVE
34	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	INACTIVE
35	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
36	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	GALLIC ACID	ACTIVE
37	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	INACTIVE
38	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	ACTIVE
39	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MORIN	ACTIVE
40	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	INACTIVE
41	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
42	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	MYRICETIN	ACTIVE
43	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
44	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	INACTIVE
45	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETIN	ACTIVE
46	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETAGETIN	WEAK ACTIVITY
47	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETAGETIN	ACTIVE
48	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	QUERCETAGETIN	WEAK ACTIVITY
49	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
50	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	INACTIVE
51	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	RUTIN	ACTIVE
52	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PYROGALLOL	WEAK ACTIVITY
53	DNA SCISSION EFFECT	PHARMACOLOGY OF COMPOUND - IN VITRO	PYROGALLOL	ACTIVE
54	DNA DAMAGE PREVENTION ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	PYROGALLOL	ACTIVE

Citation 138964

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1